Displaying drugs 13401 - 13425 of 13909 in total
GSK-1521498
GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism.
Investigational
Matched Description: … GSK1521498 has been used in trials studying the treatment of Obesity and Alcoholism. …
T-62
T-62 has been used in trials studying the treatment of Postherpetic Neuralgia.
Investigational
Matched Description: … T-62 has been used in trials studying the treatment of Postherpetic Neuralgia. …
Leukotriene B4
Leukotriene B4 has been used in trials studying the treatment of HIV Infections.
Investigational
Matched Description: … Leukotriene B4 has been used in trials studying the treatment of HIV Infections. …
Henatinib
Henatinib has been used in trials studying the treatment of Advanced Solid Cancer.
Investigational
Matched Description: … Henatinib has been used in trials studying the treatment of Advanced Solid Cancer. …
Torapsel
Torapsel has been used in trials studying the prevention of Ischemia Reperfusion Injury.
Investigational
Matched Description: … Torapsel has been used in trials studying the prevention of Ischemia Reperfusion Injury. …
TAK-593
TAK-593 has been used in trials studying the treatment of Solid Tumors.
Investigational
Matched Description: … TAK-593 has been used in trials studying the treatment of Solid Tumors. …
Dactolisib
Dactolisib has been used in trials studying the treatment of Cancer, Solid Tumor, Renal Cancer, Breast Cancer, and Cowden Syndrome, among others.
Investigational
Matched Description: … Dactolisib has been used in trials studying the treatment of Cancer, Solid Tumor, Renal Cancer, Breast …
Uprosertib
Uprosertib has been used in trials studying the treatment of Cancer, Melanoma, Solid Tumours, Cervical Cancer, and HER2/Neu Negative, among others.
Investigational
Matched Description: … Uprosertib has been used in trials studying the treatment of Cancer, Melanoma, Solid Tumours, Cervical …
LY-3023414
LY3023414 has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST CANCER, and Advanced Cancer, among others.
Investigational
Matched Description: … LY3023414 has been used in trials studying the treatment of Neoplasm, Solid Tumor, COLON CANCER, BREAST …
Merestinib
Merestinib has been used in trials studying the treatment of Cancer, Solid Tumor, Advanced cancer, ColoRectal Cancer, and Metastatic Cancer, among others.
Investigational
Matched Description: … Merestinib has been used in trials studying the treatment of Cancer, Solid Tumor, Advanced cancer, ColoRectal …
Samarium
Samarium has been used in trials studying the treatment and prevention of Pain, Cancer, Metastasis, Prostate Cancer, and Metastatic Osteosarcoma, among others.
Investigational
Matched Description: … Samarium has been used in trials studying the treatment and prevention of Pain, Cancer, Metastasis, Prostate …
Fasiglifam
Fasiglifam has been used in trials studying the treatment of Chronic Kidney Disease, Type 2 Diabetes Mellitus, and Diabetes Mellitus, Type 2.
Investigational
Matched Description: … Fasiglifam has been used in trials studying the treatment of Chronic Kidney Disease, Type 2 Diabetes …
Naptumomab estafenatox
Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell Carcinoma, and Non-Small-Cell Lung Carcinoma.
Investigational
Matched Description: … Naptumomab Estafenatox has been used in trials studying the treatment of Pancreatic Cancer, Renal Cell …
Ombrabulin
Ombrabulin has been used in trials studying the treatment of Sarcoma, Neoplasms, Solid Tumor, Neoplasms, Malignant, and Advanced Solid Tumors, among others.
Investigational
Matched Description: … Ombrabulin has been used in trials studying the treatment of Sarcoma, Neoplasms, Solid Tumor, Neoplasms …
Samarium Sm-153
Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer, Prostate Cancer, and Metastatic Cancer.
Investigational
Matched Description: … Samarium 153 has been used in trials studying the supportive care of Pain, Lung Cancer, Breast Cancer …
Sevuparin
Sevuparin is under investigation in clinical trial NCT03853421 (Placebo-controlled Study to Determine the Safety and Tolerability of Subcutaneous Doses of Sevuparin).
Investigational
Matched Description: … Sevuparin is under investigation in clinical trial NCT03853421 (Placebo-controlled Study to Determine …
SEphB4-HSA
SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors).
Investigational
Matched Description: … SEphB4-HSA is under investigation in clinical trial NCT02495896 (Recombinant EphB4-HSA Fusion Protein ... With Standard Chemotherapy Regimens in Treating Patients With Advanced or Metastatic Solid Tumors). …
JNJ-42165279
Jnj-42165279 is under investigation in clinical trial NCT02498392 (An Efficacy, Safety and Tolerability Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress).
Investigational
Matched Description: … Study of JNJ-42165279 in Participants With Major Depressive Disorder With Anxious Distress). ... Jnj-42165279 is under investigation in clinical trial NCT02498392 (An Efficacy, Safety and Tolerability …
Lisavanbulin
Lisavanbulin is under investigation in clinical trial NCT02895360 (Phase 1/2a Study of BAL101553 as 48-hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma).
Investigational
Matched Description: … -hour Infusions in Patients With Advanced Solid Tumors or Recurrent Glioblastoma). ... Lisavanbulin is under investigation in clinical trial NCT02895360 (Phase 1/2a Study of BAL101553 as 48 …
SAR-125844
SAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors).
Investigational
Matched Description: … as Slow Intravenous Infusion in Adult Patients With Advanced Malignant Solid Tumors). ... SAR-125844 is under investigation in clinical trial NCT01391533 (Study of SAR125844 Single Agent Administered …
V116517
V116517 is under investigation in clinical trial NCT01688947 (Analgesic Efficacy and Safety of V116517 in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)).
Investigational
Matched Description: … in Subjects With Moderate to Severe Chronic Pain Due to Postherpetic Neuralgia (PHN)). ... V116517 is under investigation in clinical trial NCT01688947 (Analgesic Efficacy and Safety of V116517 …
Gancotamab
Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast Cancer Patients).
Investigational
Matched Description: … Gancotamab is under investigation in clinical trial NCT02213744 (MM-302 Plus Trastuzumab vs. ... Chemotherapy of Physician's Choice Plus Trastuzumab in HER2-Positive Locally Advanced/Metastatic Breast …
MIP-1095 I-131
MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)).
Investigational
Matched Description: … (131I-MIP-1095) in Men With Metastatic Castration-Resistant Prostate Cancer (mCRPC)). ... MIP-1095 I-131 is under investigation in clinical trial NCT03030885 (Use of an Experimental Radiopharmaceutical …
Teceleukin
Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic Ductal Adenocarcinoma).
Investigational
Matched Description: … Teceleukin is under investigation in clinical trial NCT03610490 (Autologous Tumor Infiltrating Lymphocytes ... MDA-TIL in Treating Patients With Recurrent or Refractory Ovarian Cancer, Osteosarcoma, or Pancreatic …
Nazartinib
Nazartinib is under investigation in clinical trial NCT03529084 (Phase III Study of Nazartinib (EGF816) Versus Erlotinib/gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations).
Investigational
Matched Description: … Nazartinib is under investigation in clinical trial NCT03529084 (Phase III Study of Nazartinib (EGF816 ... ) Versus Erlotinib/gefitinib in First-line Locally Advanced / Metastatic NSCLC With EGFR Activating Mutations …
Displaying drugs 13401 - 13425 of 13909 in total